Cardinal Health (NYSE:CAH) Price Target Raised to $136.00 at Wells Fargo & Company

Cardinal Health (NYSE:CAH - Get Free Report) had its price objective lifted by stock analysts at Wells Fargo & Company from $135.00 to $136.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Wells Fargo & Company's target price would indicate a potential upside of 6.57% from the stock's previous close.

Several other research firms have also commented on CAH. JPMorgan Chase & Co. upped their price target on shares of Cardinal Health from $132.00 to $142.00 and gave the company a "neutral" rating in a report on Friday, January 24th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a research note on Monday, November 4th. UBS Group increased their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a research note on Monday, November 4th. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target for the company in a research report on Tuesday, January 7th. Finally, Bank of America upgraded Cardinal Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $136.87.

Cardinal Health Price Performance

CAH stock traded up $0.57 during midday trading on Tuesday, reaching $127.62. The company had a trading volume of 1,425,003 shares, compared to its average volume of 2,370,496. Cardinal Health has a 1 year low of $93.17 and a 1 year high of $132.84. The firm has a 50-day moving average price of $122.35 and a 200-day moving average price of $114.92. The company has a market capitalization of $30.83 billion, a P/E ratio of 23.81, a P/E/G ratio of 1.46 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities analysts predict that Cardinal Health will post 7.92 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Czech National Bank increased its stake in shares of Cardinal Health by 7.0% in the 3rd quarter. Czech National Bank now owns 49,673 shares of the company's stock valued at $5,490,000 after buying an additional 3,259 shares during the period. GAMMA Investing LLC lifted its position in Cardinal Health by 34.0% during the 3rd quarter. GAMMA Investing LLC now owns 3,557 shares of the company's stock worth $393,000 after buying an additional 902 shares in the last quarter. Exeter Financial LLC grew its stake in shares of Cardinal Health by 0.9% in the third quarter. Exeter Financial LLC now owns 14,757 shares of the company's stock valued at $1,631,000 after buying an additional 128 shares in the last quarter. Alpha Cubed Investments LLC bought a new stake in Cardinal Health in the 3rd quarter valued at $371,000. Finally, Insight Wealth Strategies LLC grew its position in shares of Cardinal Health by 1.9% in the third quarter. Insight Wealth Strategies LLC now owns 19,483 shares of the company's stock valued at $2,153,000 after purchasing an additional 365 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.